Pajzsmirigyrák: vizsgálatok itt: Dél-Korea
6 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 1. fázisTaking peoplePhase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Where
- Seoul
- Életkor
- 18 év to 100 év
- People
- 116 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Hwasun, Pusan, Seoul, Suwon
- Életkor
- 8 év and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - 2. fázisNot yet taking people in Dél-KoreaSacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
- Where
- Gyeonggi-do, Seoul
- Életkor
- 18 év to 99 év
- People
- 68 worldwide
- Run by
- National Cancer Centre, Singapore
See details and how to joinNCT07521670 - 1/2. fázisTaking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Cheongju-si, Hwasun-eup, Hwasun-gun, Seoul
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseTaking peopleAn Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T)
- Where
- Gyeonggi-do, Seoul
- Életkor
- 19 év and over
- People
- 500
- Run by
- Ilsan Cha hospital
See details and how to joinNCT06158360 - No phaseCsak meghívásosActive Surveillance for Low-risk Papillary Thyroid Carcinoma
- Where
- Goyang-si, Seongnam, Seoul
- Életkor
- 18 év and over
- People
- 499
- Run by
- National Cancer Center, Korea
See details and how to joinNCT06261190